158 related articles for article (PubMed ID: 2798596)
1. Specificity of plasma HVA response to dexamethasone in psychotic depression.
Wolkowitz OM; Doran A; Breier A; Roy A; Pickar D
Psychiatry Res; 1989 Aug; 29(2):177-86. PubMed ID: 2798596
[TBL] [Abstract][Full Text] [Related]
2. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and outpatients.
Syvälahti E
Acta Psychiatr Scand; 1985 Feb; 71(2):105-10. PubMed ID: 3976406
[TBL] [Abstract][Full Text] [Related]
4. Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients.
Meltzer HY; Fang VS; Tricou BJ; Robertson A; Piyaka SK
Am J Psychiatry; 1982 Jun; 139(6):763-8. PubMed ID: 7081489
[TBL] [Abstract][Full Text] [Related]
5. [The concept of atypical depression].
Garre JB
Encephale; 1992 Dec; 18 Spec No 5():721-5. PubMed ID: 1342672
[No Abstract] [Full Text] [Related]
6. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
Mazure CM; Nelson JC; Jatlow PI; Bowers MB
Biol Psychiatry; 1991 Sep; 30(5):475-82. PubMed ID: 1932395
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term outcome of schizophrenic, affective and schizoaffective disorders.
Marneros A; Deister A; Rohde A
Br J Psychiatry Suppl; 1992 Oct; (18):44-51. PubMed ID: 1389041
[No Abstract] [Full Text] [Related]
8. Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder.
Fennig S; Bromet EJ; Karant MT; Ram R; Jandorf L
J Affect Disord; 1996 Feb; 37(1):23-9. PubMed ID: 8682975
[TBL] [Abstract][Full Text] [Related]
9. Plasma HVA levels in depressed patients and controls.
Roy A
J Affect Disord; 1988; 14(3):293-6. PubMed ID: 2968391
[TBL] [Abstract][Full Text] [Related]
10. Response to dexamethasone in psychotic depression.
Caroff S; Winokur A; Rieger W; Schweizer E; Amsterdam J
Psychiatry Res; 1983 Jan; 8(1):59-64. PubMed ID: 6572988
[TBL] [Abstract][Full Text] [Related]
11. Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features.
Pini S; Cassano GB; Dell'Osso L; Amador XF
Am J Psychiatry; 2001 Jan; 158(1):122-5. PubMed ID: 11136644
[TBL] [Abstract][Full Text] [Related]
12. The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups.
Mendlewicz J; Charles G; Franckson JM
Br J Psychiatry; 1982 Nov; 141():464-70. PubMed ID: 7150882
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
Kraus RP; Remick RA
J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
[TBL] [Abstract][Full Text] [Related]
14. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
Bowers MB; Mazure CM; Nelson JC; Jatlow PI
Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190
[TBL] [Abstract][Full Text] [Related]
15. Negative symptoms in the course of first-episode affective psychosis.
Husted JA; Beiser M; Iacono WG
Psychiatry Res; 1995 Mar; 56(2):145-54. PubMed ID: 7667439
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone nonsuppression in chronic schizophrenia.
Whiteford HA; Riney SJ; Savala RA; Csernansky JG
Acta Psychiatr Scand; 1988 Jan; 77(1):58-62. PubMed ID: 3273153
[TBL] [Abstract][Full Text] [Related]
17. Depression, negative and positive symptoms, and the DST in schizophrenia.
Minas IH; Jackson HJ; Joshua SD; Burgess PM
Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
[TBL] [Abstract][Full Text] [Related]
18. The dexamethasone suppression test in psychotic disorders.
Arana GW; Barreira PJ; Cohen BM; Lipinski JF; Fogelson D
Am J Psychiatry; 1983 Nov; 140(11):1521-3. PubMed ID: 6625007
[TBL] [Abstract][Full Text] [Related]
19. The dexamethasone suppression test in residual schizophrenia with depression.
Munro JG; Hardiker TM; Leonard DP
Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
[TBL] [Abstract][Full Text] [Related]
20. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression.
Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM
Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
